Clinical Trials
28 trialsINDIGO
Boston Scientific Corporation
BRAVESST2
Crinetics Pharmaceuticals Inc.
STELLAR-311
Exelixis
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Circle Pharma
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Hutchmed
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
National Cancer Institute (NCI)
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
University of Sao Paulo
EVACEL
Federation Francophone de Cancerologie Digestive
Cryoablation of Bone Metastases From Endocrine Tumors
Instituto do Cancer do Estado de São Paulo
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
H. Lee Moffitt Cancer Center and Research Institute
REGOMUNE
Institut Bergonié
A Study of Pembrolizumab in Patients With Neuroendocrine Tumors
Fox Chase Cancer Center
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
H. Lee Moffitt Cancer Center and Research Institute
DEBOXA for Inoperable NET Liver Metastases
Xiangya Hospital of Central South University
RMPanNET
Fudan University
A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
Eli Lilly and Company
LyREMeNet
Hospices Civils de Lyon
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
Eli Lilly and Company
High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors
M.D. Anderson Cancer Center
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
EPO906 in Carcinoid and Other Neuroendocrine Tumors
Novartis
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
H. Lee Moffitt Cancer Center and Research Institute
Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization
H. Lee Moffitt Cancer Center and Research Institute
NEO-LEBE
University of Jena